Your session is about to expire
← Back to Search
Cancer Vaccine
Beta Alethine for Lymphoma
Phase 1 & 2
Waitlist Available
Research Sponsored by LifeTime Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Histologically confirmed low grade B-cell lymphoma
Measurable residual disease after maximal response to prior chemotherapy OR indolent disease not yet requiring therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well beta alethine works in treating patients with low-grade lymphoma.
Who is the study for?
This trial is for adults with low-grade B-cell lymphoma who have either measurable disease after chemotherapy or indolent disease not yet treated. They must be in good health otherwise, with adequate blood counts and liver/kidney function, and no severe heart issues or active infections. Pregnant/nursing individuals, HIV/AIDS patients, those on certain medications like anti-inflammatories or immunosuppressants are excluded.Check my eligibility
What is being tested?
The trial is testing beta alethine's ability to boost the immune system against lymphoma. It's a Phase I/II study which means they're looking at how safe it is (Phase I) and how well it works (Phase II). Participants will receive beta alethine to see if it can stop their cancer from growing.See study design
What are the potential side effects?
Potential side effects of beta alethine may include reactions related to the immune system being activated such as fever, fatigue, skin reactions at injection sites, flu-like symptoms, and possibly changes in blood cell counts leading to increased risk of infections.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer is a type of low grade B-cell lymphoma.
Select...
I still have cancer signs after the best outcome from my last chemotherapy OR my cancer is slow-growing and doesn’t need treatment yet.
Select...
I can take care of myself but may not be able to do active work.
Select...
My kidney function is good, with creatinine levels at or below 2.0 mg/dL.
Select...
I am 18 years old or older.
Select...
My liver function tests are within the required range.
Select...
My heart condition is stable with no recent issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
LifeTime PharmaceuticalsLead Sponsor
2 Previous Clinical Trials
1 Trials studying Lymphoma
Suzin Mayerson, PhDStudy ChairLifeTime Pharmaceuticals
2 Previous Clinical Trials
1 Trials studying Lymphoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have lymphoma that started in my brain.I am not currently taking any corticosteroids.I am not taking any anti-inflammatory drugs, including aspirin.I do not have lymphoma caused by a birth-related immune deficiency.My cancer is a type of low grade B-cell lymphoma.I still have cancer signs after the best outcome from my last chemotherapy OR my cancer is slow-growing and doesn’t need treatment yet.I can take care of myself but may not be able to do active work.My kidney function is good, with creatinine levels at or below 2.0 mg/dL.I have not had any organ transplant surgeries.I am 18 years old or older.My cancer has not spread to my brain or its coverings.I am not taking any drugs that weaken my immune system.My liver function tests are within the required range.My heart condition is stable with no recent issues.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial currently recruiting participants?
"The entry on clinicaltrials.gov suggests that this medical study is not currently accepting new participants, as the original posting was in August of 2000 and it has since been edited for the last time in December 2013. Nonetheless, there are 1,718 other trials actively looking for patients to enroll at this moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger